Peter Krippl Selected Research

TNF-Related Apoptosis-Inducing Ligand Receptors

2/2008

The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Krippl Research Topics

Disease

21	Neoplasms (Cancer) 09/2018 - 09/2003
20	Breast Neoplasms (Breast Cancer) 03/2015 - 06/2003
7	Neoplasm Metastasis (Metastasis) 03/2015 - 12/2004
3	Colorectal Neoplasms (Colorectal Cancer) 04/2011 - 05/2008
3	Prostatic Neoplasms (Prostate Cancer) 07/2008 - 02/2007
2	Primary Myelofibrosis (Myelosclerosis) 09/2018 - 05/2017
2	Carcinogenesis 02/2006 - 05/2004
1	Cardiac Arrhythmias (Arrythmia) 09/2017
1	Atrial Fibrillation 09/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2012
1	Hemorrhage 02/2012
1	Hypoxia (Hypoxemia) 09/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2010
1	Peripheral Arterial Disease 02/2010
1	Inflammation (Inflammations) 02/2010
1	Mesothelioma 11/2006
1	Poliomyelitis (Polio) 11/2006
1	Lymphatic Metastasis 02/2006
1	Vomiting 01/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2006
1	Hearing Loss (Hearing Impairment) 01/2006
1	Nausea 01/2006
1	Acute Kidney Injury (Acute Renal Failure) 01/2006

Drug/Important Bio-Agent (IBA)

7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 09/2003
6	Progesterone Receptors (Progesterone Receptor)IBA 02/2010 - 09/2003
4	Interleukin-10 (Interleukin 10)IBA 12/2010 - 03/2005
4	Estrogens (Estrogen)FDA Link 03/2005 - 09/2003
3	EnzymesIBA 05/2017 - 09/2003
3	IntegrinsIBA 04/2011 - 05/2006
2	ruxolitinibIBA 09/2018 - 05/2017
2	Estrogen ReceptorsIBA 11/2010 - 02/2010
2	Folic Acid (Vitamin M)FDA LinkGeneric 02/2010 - 09/2003
2	Cyclin D1IBA 07/2005 - 12/2003
1	Phosphotransferases (Kinase)IBA 09/2018
1	Azacitidine (5 Azacytidine)FDA Link 11/2014
1	Inosine Triphosphate (ITP)IBA 02/2012
1	Epirubicin (Ellence)FDA LinkGeneric 06/2011
1	Tamoxifen FDA LinkGeneric 11/2010
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2010
1	Proteins (Proteins, Gene)FDA Link 09/2010
1	Monoclonal AntibodiesIBA 09/2010
1	Oxygen (Dioxygen)IBA 09/2010
1	ProstaglandinsIBA 02/2010
1	Factor XII (Hageman Factor)IBA 02/2010
1	Capecitabine (Xeloda)FDA Link 01/2010
1	Tyrosine Kinase InhibitorsIBA 01/2010
1	Lapatinib (GW572016)FDA Link 01/2010
1	LigandsIBA 02/2008
1	Cysteine (L-Cysteine)FDA Link 02/2008
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2008
1	DNA (Deoxyribonucleic Acid)IBA 11/2006
1	AsbestosIBA 11/2006
1	VaccinesIBA 11/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2006
1	Cisplatin (Platino)FDA LinkGeneric 01/2006
1	CytokinesIBA 03/2005
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2004
1	Arginine (L-Arginine)FDA Link 09/2004
1	Histidine (L-Histidine)FDA Link 09/2004
1	Amino Acids FDA Link 09/2004
1	SulfotransferasesIBA 09/2004
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 05/2004
1	GTP-Binding Proteins (G-Protein)IBA 03/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2003
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2003
1	HomocysteineIBA 09/2003
1	PlatinumIBA 06/2003

Therapy/Procedure

3	Therapeutics 09/2018 - 01/2010
3	Drug Therapy (Chemotherapy) 06/2011 - 06/2003
1	Art Therapy 09/2017
1	Stem Cell Transplantation 05/2017
1	Radiotherapy 02/2008
1	Lasers (Laser) 07/2006
1	Adjuvant Chemotherapy 06/2003